Spire Homolog 2 (SPIRE2) Peptide
-
- Target See all SPIRE2 products
- SPIRE2 (Spire Homolog 2 (SPIRE2))
- Peptide Type
- Synthetic
- Origin
- Mammalian
- Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Sequence
- EAQTVQSLGF AIYRALDWGL DESEERELSP QLERLIDLMA NNDSEDSGCG
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SPIRE2 antibody,
Alternative Names: SPIRE2 control peptide, SPIRE2 antibody Blocking Peptide, Anti-SPIRE2 Blocking Peptide, spire homolog 2, Drosophila Blocking Peptide, MGC117166 Blocking Peptide, Spir-2 Blocking Peptide, SPIRE2, SPIRE-2, SPIRE 2, SPIRE-2 Blocking Peptide, SPIRE 2 Blocking Peptide
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- SPIRE2 (Spire Homolog 2 (SPIRE2))
- Background
- SPIRE2 acts as a actin nucleation factor, remains associated with the slow-growing pointed end of the new filament. It is involved in vesicle transport processes providing a novel link between actin organization and intracellular transport.
- Molecular Weight
- 80 kDa
-